Considering the low prevalence of TBM worldwide (1% among patients with pulmonary TB) (Wilkinson et al., 2017), the proportion of TBM in the meningitis population with elevated CSF-ADA levels might be very low, especially in a non-TB endemic area. This evidence concerns the gene ADA and meningeal tuberculosis.